Human immunodeficiency virus-associated lipoatrophy: letting the genome out of the bottle.
Lichtenstein
Kenneth A
KA
D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D020022:Genetic Predisposition to Disease; D015894:Genome, Human; D006678:HIV / Q000302:isolation & purification*; D039682:HIV-Associated Lipodystrophy Syndrome / Q000235:genetics*; D006801:Humans; D020641:Polymorphism, Single Nucleotide